Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease

Time Course of Glucose Metabolism in Relation to Cognitive Performance and Postmortem Neuropathology in Met146Val PSEN1 Mutation Carriers

(2018) Michael Schöll et al.   JOURNAL OF ALZHEIMERS DISEASE

A Novel PSEN1 Mutation (I238M) associated with Early-Onset Alzheimer's Disease in an African-American Woman

(2018) Simon Kang Seng Ting et al.   JOURNAL OF ALZHEIMERS DISEASE

Metabolic Correlates of Rey Auditory Verbal Learning Test in Elderly Subjects with Memory Complaints

(2018) Andrea Brugnolo et al.   JOURNAL OF ALZHEIMERS DISEASE

Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

(2017) Valentina Garibotto et al.   NEUROBIOLOGY OF AGING

Hippocampal hypometabolism in older adults with memory complaints and increased amyloid burden

(2017) Patrizia Vannini et al.   NEUROLOGY

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

(2016) Bruno Dubois et al.   Alzheimers & Dementia

Differential Risk of Incident Alzheimer’s Disease Dementia in Stable Versus Unstable Patterns of Subjective Cognitive Decline

(2016) Steffen Wolfsgruber et al.   JOURNAL OF ALZHEIMERS DISEASE

Complementarity of visual and voxel-based FDG-PET analysis to detect MCI-like hypometabolic pattern in elderly patients with hypertension and isolated memory complaints

(2015) Axel Van Der Gucht et al.   ACTA RADIOLOGICA

Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study

(2015) Wai-Ying Wendy Yau et al.   LANCET NEUROLOGY

The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function

(2015) N. Maritza Dowling et al.   NEUROIMAGE

Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography

(2015) Michael Schöll et al.   Scientific Reports

Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment

(2014) E. Auning et al.   ACTA PSYCHIATRICA SCANDINAVICA

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

(2014) Frank Jessen et al.   Alzheimers & Dementia

18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons

(2014) David S. Knopman et al.   NEUROBIOLOGY OF AGING

Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2012

(2013) M. A. Leone et al.   EUROPEAN JOURNAL OF NEUROLOGY

Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints

(2013) Agnese Picco et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Cognitive reserve associated with FDG-PET in preclinical Alzheimer disease

(2013) M. Ewers et al.   NEUROLOGY

Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease

(2013) T. L. S. Benzinger et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects

(2013) Michael Ewers et al.   NeuroImage-Clinical

MR, 18F-FDG, and 18F-AV45 PET Correlate With AD PSEN1 Original Phenotype

(2012) Laure Saint-Aubert et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

The Ups and Downs of the Posteromedial Cortex: Age- and Amyloid-Related Functional Alterations of the Encoding/Retrieval Flip in Cognitively Normal Older Adults

(2012) Patrizia Vannini et al.   CEREBRAL CORTEX

A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease

(2012) Agneta Nordberg et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: A cross-validation study using voxel-based multi-modal partial least squares

(2012) Kewei Chen et al.   NEUROIMAGE

Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment

(2012) L. Scheef et al.   NEUROLOGY

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

(2012) Randall J. Bateman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Posterior Cingulate Glucose Metabolism, Hippocampal Glucose Metabolism, and Hippocampal Volume in Cognitively Normal, Late-Middle-Aged Persons at 3 Levels of Genetic Risk for Alzheimer Disease

(2012) Hillary D. Protas et al.   JAMA Neurology

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

(2011) Victor L. Villemagne et al.   ANNALS OF NEUROLOGY

Dissociating behavioral disorders in early dementia—An FDG-PET study

(2011) Matthias L. Schroeter et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

(2011) Randall J Bateman et al.   Alzheimers Research & Therapy

The Value of PET in Mild Cognitive Impairment, Typical and Atypical/Unclear Dementias: A Retrospective Memory Clinic Study

(2010) Robert Laforce et al.   American Journal of Alzheimers Disease and Other Dementias

Hypometabolism in Alzheimer-Affected Brain Regions in Cognitively Healthy Latino Individuals Carrying the Apolipoprotein E ε4 Allele

(2010) Jessica B. S. Langbaum et al.   ARCHIVES OF NEUROLOGY

Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation

(2010) John M. Ringman et al.   NEUROSCIENCE LETTERS

Preclinical Evidence of Alzheimer Changes

(2009) Eric C. Petrie et al.   ARCHIVES OF NEUROLOGY

A novel presenilin1 mutation (Q223R) associated with early onset Alzheimer’s disease, dysarthria and spastic paraparesis and decreased Abeta levels in CSF

(2009) I. Uttner et al.   EUROPEAN JOURNAL OF NEUROLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation

(2009) Michael Schöll et al.   NEUROBIOLOGY OF AGING

Hypometabolism and Altered Cerebrospinal Fluid Markers in Normal Apolipoprotein E E4 Carriers with Subjective Memory Complaints

(2007) Lisa Mosconi et al.   BIOLOGICAL PSYCHIATRY